Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net loss	$ (55,983)	$ (41,079)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	9,652	7,767
Amortization of intangible assets	26,977	18,937
Provision for doubtful accounts and allowance for sales returns	4,317	898
Stock-based compensation	13,935	9,874
Other non-cash charges	628	2,267
Changes in operating assets and liabilities, net
Accounts receivable	41,620	(24,171)
Inventories	(9,702)	(13,313)
Prepaid expenses and other assets	806	(1,354)
Accounts payable	9,070	(5,404)
Accrued compensation and benefits	(6,176)	(1,764)
Deferred revenue	(1,331)	10,796
Deferred distributor revenue, net of cost of sales to distributors	3,696	6,829
Other current and long term liabilities	(3,945)	(900)
Net cash provided by (used in) operating activities	33,564	(30,617)
Cash flows from investing activities:
Capital expenditures	(5,610)	(17,384)
Acquisition, net of cash acquired	0	(180,000)
Purchases of investments	0	(9,045)
Purchases of non-marketable equity investments	(3,000)	0
Proceeds from maturities of investments and marketable securities	21,815	26,722
Proceeds from sales of investments and marketable securities	9,051	56,594
Purchases of intangible assets	(569)	0
Net cash provided by (used in) investing activities	21,687	(123,113)
Cash flows from financing activities:
Borrowings under Revolving Facility	24,000	59,000
Issuance of Term Loan	0	65,000
Repayment of debt	(77,062)	(1,625)
Proceeds from issuance of common stock	2,455	6,296
Net cash (used in) provided by financing activities	(50,607)	128,671
Foreign currency effect on cash	(3,767)	611
Net increase (decrease) in cash and cash equivalents	877	(24,448)
Cash and cash equivalents at beginning of period	73,190	95,803
Cash and cash equivalents at end of period	$ 74,067	$ 71,355